Anemia Assessment

  • Christine A. HughesEmail author


Anemia is diagnosed based on a decrease in hemoglobin (Hgb) or red blood cell (RBC) count. Anemia is not a disease itself but reflects an underlying condition; therefore, it is important to identify the cause. Anemia is commonly encountered in clinical practice, and pharmacists can play an important role in assessment, treatment, and follow-up. Patients with anemia may be asymptomatic or have nonspecific signs and symptoms depending on the severity of anemia and duration of onset. Laboratory tests are essential in the diagnosis of anemia and should be evaluated in the context of the patient history and physical examination. Several medical conditions and medications, as well as dietary deficiency of iron, folate, and vitamin B12, can lead to the development of anemia. Anemia can be categorized as microcytic, normocytic, and macrocytic based on the mean corpuscular volume (MCV). This classification is useful in narrowing down potential causes of anemia and additional investigations that are needed. Management of anemia may include treating the underlying disease or replacement of iron, folic acid, or vitamin B12 deficiency.


Anemia Evaluation Microcytic Normocytic Macrocytic Iron deficiency Vitamin B12 Folate Hemoglobin Management 


  1. 1.
    Vieth JT, Lane DR. Anemia. Emerg Med Clin North Am. 2014;32:613–28.CrossRefGoogle Scholar
  2. 2.
    WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011. (WHO/NMH/NHD/MNM/11.1) Available at: (accessed May 29, 2018).Google Scholar
  3. 3.
    Le CHH. The prevalence of anemia and moderate-severe anemia in the US population (NHANES 2003-2012). PLoS One. 2016;11(11):e0166635. Scholar
  4. 4.
    Cascio MJ, DeLoughery TG. Anemia: evaluation and diagnostic tests. Med Clin N Am. 2017;101:263–84.CrossRefGoogle Scholar
  5. 5.
    Kujovich JL. Evaluation of anemia. Obstet Gynecol Clin N Am. 2016;43:247–64.CrossRefGoogle Scholar
  6. 6.
    Toward Optimized Practice Iron Deficiency Anemia Committee. Iron deficiency anemia clinical practice guideline. Edmonton: Toward Optimized Practice; 2018. Available from: (accessed May 30, 2018).Google Scholar
  7. 7.
    Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anemia. Lancet. 2016;387:907–16.CrossRefGoogle Scholar
  8. 8.
    CPS [Internet]. Iron preparations: oral. Ottawa: Canadian Pharmacists Association; 2018. (updated November 2017; cited May 30, 2018). Available at: Scholar
  9. 9.
    Green R, Mitra AD. Megaloblastic anemias: nutritional and other causes. Med Clin North Am. 2017;101:2979–317.CrossRefGoogle Scholar
  10. 10.
    U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;150:626–31.CrossRefGoogle Scholar
  11. 11.
    Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician. 2017;96:384–9.Google Scholar
  12. 12.
    CPS [Internet]. Vitamin B12. Ottawa: Canadian Pharmacists Association; 2018. (updated July 2012; cited May 30, 2018). Available at: Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University of Alberta, Faculty of Pharmacy and Pharmaceutical SciencesEdmontonCanada

Personalised recommendations